ResMed Inc News

AU Weekly Wrap | ASX Slips Back Below 8000; DroneShield Shares Tumble Despite Revenue Increase

Moomoo News AUJul 26 08:21 ET

ASX 200's Highest-Paid CEOs: Who Leads the Pack?

Moomoo News AUJul 26 06:25 ET

ResMed Price Target Raised 1.6% to A$35.40/Share by Macquarie

Dow JonesJul 24 18:47 ET · Ratings

ResMed Is Maintained at Sector Perform by RBC Capital

Dow JonesJul 23 07:42 ET

ResMed Price Target Raised to $204.00/Share From $200.00 by RBC Capital

Dow JonesJul 23 07:42 ET · Ratings

Express News | Resmed Inc : RBC Raises Target Price to $204 From $200

ReutersJul 23 02:29 ET

Australian Stocks With U.S. Exposure Could Be a 'Trump Trade' Bet -- Market Talk

WSJJul 21 21:21 ET

Express News | Resmed Inc : UBS Raises Target Price to $210 From $195

ReutersJul 19 08:56 ET

Do Weight Loss Drugs Pose a Threat to ResMed Shares?

The Motley FoolJul 18 23:18 ET

Buy Resmed Shares at 'Attractive Entry Level' Says Top Broker

The Motley FoolJul 15 21:10 ET

Why the ResMed Share Price Tanked in FY 2024 and What to Expect in FY 2025

The Motley FoolJul 13 16:00 ET

GLP-1 Concerns Clobbered This Healthcare Stock. Now It's Time to Buy.

Barron'sJul 12 22:07 ET

Express News | Resmed Inc : BofA Global Research Raises Price Objective to $230 From $225

ReutersJul 12 09:04 ET

These Top ASX 200 Growth Shares Could Rise 20% to 45%

The Motley FoolJul 10 19:39 ET

Insider Sale: CFO Brett Sandercock Sells Shares of ResMed Inc (RMD)

InvestingJul 9 19:29 ET

Where to Invest $10,000 in ASX 200 Shares in July

The Motley FoolJul 1 20:01 ET

Resmed Inc CDI Holdings See Monthly Dip

TipRanksJul 1 19:02 ET

What's the Outlook for ASX Healthcare Shares in FY25?

The Motley FoolJul 1 15:30 ET

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Barron'sJun 27 12:01 ET

Should You Pounce on ResMed Shares at Around $28?

The Motley FoolJun 26 23:04 ET